Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT00328458
Eligibility Criteria:
Inclusion Criteria:
* Requires a minimum of 3 weeks of radiation therapy
* Solid tumors with advanced or recurrent disease for which there is no standard therapy or tumors have failed standard therapy
* World Health Organization (WHO) performance status equal to or less than 2
* Life expectancy equal to or greater than 3 months
Exclusion Criteria:
* Any peripheral neuropathy
* Unresolved diarrhea greater than grade 1
* Patients who received any other investigational compound within the past 28 days
* Severe cardiac insufficiency
* Patients on Coumadin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00328458
Study Brief:
Protocol Section:
NCT00328458